POSTER SESSION IV
Tuesday, March 23, 2010 — 1:00 PM - 4:30 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
PULMONARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
246
High Prevalence of Atypical Mesothelial Proliferation in Extrapleural Pneumonectomy Specimens; Further Evidence of a Potential Precursor Lesion to Invasive Mesothelioma?
(1792)
LA Doyle, JM Corson, DJ Sugarbaker, LR Chirieac - Brigham and Women's Hospital, Boston, MA
Clinicopathologic Characteristics of Malignant Mesotheliomas Arising in Patients with a History of Radiation for Hodgkin Lymphoma
(1774)
JA Barletta, J Godleski, DJ Sugarbaker, LR Chirieac - Brigham and Women's Hospital, Boston, MA
DNA Mismatch Repair Deficiency in Malignant Pleural Mesotheliomas
(1809)
Y Karamurzin, JKL Rutgers - University of California, Irvine, CA; Todd Cancer Institute, Long Beach Memorial Medical Center, Long Beach, CA
Utility of Glucose Transporter 1 in the Differentiation of Peritoneal and Pleural Mesothelioma from Non-Malignant Mesothelium
(1814)
SM Lagana, RN Taub, AC Borczuk - Columbia University Medical Center, New York, NY
Immunohistochemical Detection of Monocarboxylate Transporters (MCT) and GLUT-1 in Pleural Malignant Mesothelioma and Reactive Mesothelial Hyperplasia: A Useful Tool for the Differential Diagnosis
(1800)
M Hamasaki, A Mogi, K Nabeshima, N Uesugi, K Tamura, A Iwasaki, T Shirakusa, H Iwasaki - Fukuoka University Hospital & School of Medicine; National Hospital Organization Kyushu Medical Center and Fukusei-Kai Hospital, Fukoka, Japan
C-MET Subcellular Localization in Patients with Malignant Mesothelioma in a Series of 157 Cases from the MESOPATH Center
(1817)
G Levallet, N Le Stang, G Zalcman, F Galateau-Salle - CHU Caen, Caen, France
Array CGH on Archival Fixed Paraffin Embedded Tissues on a Series of Malignant Mesothelioma
(1835)
M Paciencia, M Brevet, M Figeac, V Abonnet, N Le Stang, F Galateau-Salle - CHU, Caen, France; Institute of Cancer Research, Lille, France
Increased Length of Survival after Lung Transplantation Is Not Dependent on Patient Age at Transplantation - Analysis of 625 Cases from a Single Center
(1805)
Z Hu, Y Li, J Gagermeier, C Alex, R Love, M Picken - Loyola University Medical Center, Maywood
Biopsy Findings in Acute Pulmonary Histoplasmosis: Unusual Histologic Features of a Potential Mimic of Lymphomatoid Granulomatosis
(1829)
S Mukhopadhyay, A Katzenstein - State University of New York Upstate Medical University, Syracuse, NY
Identification of Early Pathologic Markers of Interstitial Lung Diseases
(1847)
LM Sholl, IE Fernandez, IO Rosas, RF Padera - Brigham and Women's Hospital, Boston, MA
Is Low-Grade Lymphomatoid Granulomatosis an IgG4-Related Interstitial Lung Disease?
(1804)
CJ Holman, J Jessurun, JG Strickler, SE Pambuccian - University of Minnesota, Minneapolis, MN; Abbott Northwestern Hospital, Minneapolis, MN
Smoking Related Interstitial Fibrosis: A Common Form of Interstitial Fibrosis in Smokers To Be Distinguished from the Fibrosing Idiopathic Interstitial Pneumonias
(1828)
S Mukhopadhyay, A Katzenstein - State University of New York Upstate Medical University, Syracuse, NY
Cathepsin k Expression in Benign Clear Cell "Sugar" Tumor of the Lung
(1799)
S Gobbo, G Martignoni, M Pea, M Brunelli, M Chilosi, F Bonetti - University of Verona, Verona, Italy; Ospedale Orlandi, Bussolengo, Italy
Immune Infiltration and Melanoma Target Antigen Expression in Lymphangioleiomyomatosis
(1811)
J Klarquist, M Picken, R Love, D Dilling, IC LePoole - Loyola University Medical Center, Maywood, IL
Mutations in the tsc2 Gene Do Not Always Play a Role in the Pathogenesis of Sporadic Lymphangioleimyomatosis
(1798)
L Gao, WQ Ling, DJ Kwiatkowski, L Schuger - University of Chicago, Chicago, IL; Harvard Medical School, Boston, MA
CD138 (Syndecan-1) in Thymic Neoplasms: Correlation with Various World Health Organization Types and Clinical Outcome
(1822)
WG Liu, OM Al-Agha, R Chandrasekhar, G Wilding, DF Tan, S Alrawi, T Khoury - State University of New York at Buffalo, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY; MD-Anderson, Houston, TX; University of Florida, Jacksonville, FL
Diagnostic Significance of Cell-Kinetic Parameters in WHO Type A and B3 Thymoma and Thymic Carcinoma
(1841)
AC Roden, ES Yi, SM Jenkins, JL Donovan, SD Cassivi, YI Garces, RS Marks, MC Aubry - Mayo Clinic, Rochester, MN
Radiation Therapy Does Not Improve the Prognosis of Patients with Stage II Thymoma, Supporting Previous Evidence Suggesting That the Presence of Transcapsular Invasion Is Not a Significant Prognostic Feature
(1825)
AM Marchevsky, RS Parakh, B Hakimian - Cedars- Sinai Medical Center, Los Angeles, CA
button next to any title to add to Itinerary Planner...
Add
